Track topics on Twitter Track topics that are important to you
John McBride has been appointed chief financial officer of Cadent Therapeutics. He was most recently the CFO of Syntimmune, which was acquired by Alexion Pharmaceuticals (NASDAQ: ALXN) last year. Camb...
Founded in 2013, Syntimmune is advancing novel therapies based on its leading position in the biology of the neonatal Fc receptor (FcRn). FcRn is a well-validated target for IgG-m...
We have published hundreds of Syntimmune, Inc. news stories on BioPortfolio along with dozens of Syntimmune, Inc. Clinical Trials and PubMed Articles about Syntimmune, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Syntimmune, Inc. Companies in our database. You can also find out about relevant Syntimmune, Inc. Drugs and Medications on this site too.
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...